SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001628280-24-031693
Filing Date
2024-07-11
Accepted
2024-07-11 16:12:56
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A avtx-20240331.htm   iXBRL 10-Q/A 873863
2 EX-31.1 ex-3111q2024amended.htm EX-31.1 10549
3 EX-31.2 ex-3121q2024amended.htm EX-31.2 10335
4 EX-32.1 ex-3211q2024amended.htm EX-32.1 11110
10 GRAPHIC avtx-20240331_g1.jpg GRAPHIC 492886
  Complete submission text file 0001628280-24-031693.txt   7032366

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20240331.xsd EX-101.SCH 56662
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20240331_cal.xml EX-101.CAL 64249
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20240331_def.xml EX-101.DEF 343046
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20240331_lab.xml EX-101.LAB 591257
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20240331_pre.xml EX-101.PRE 451707
73 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20240331_htm.xml XML 673613
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37590 | Film No.: 241112188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)